IRBESARTAN RELATED COMPOUND A (25 MG) (1-PENTANOYLAMINO-CYCLOPENTANECARBOXYLIC ACID [2'-(1H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-AMIDE)

CAS NO.：748812-53-5
Empirical Formula: C25H30N6O2
Molecular Weight: 446.54
MDL number: MFCD22380598
SAFETY DATA SHEET (SDS)
Update Date: 2025-01-27 09:38:02

What is IRBESARTAN RELATED COMPOUND A (25 MG) (1-PENTANOYLAMINO-CYCLOPENTANECARBOXYLIC ACID [2'-(1H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-AMIDE)?

The Uses of IRBESARTAN RELATED COMPOUND A (25 MG) (1-PENTANOYLAMINO-CYCLOPENTANECARBOXYLIC ACID [2'-(1H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-AMIDE)

1-[(1-Oxopentyl)amino]-N-[[2''-(2H-tetrazol-5-yl)[1,1''-biphenyl]-4-yl]methyl]-cyclopentanecarboxamide (Irbesartan EP Impurity A; Irbesartan USP Related Compound A; Irbesartan Metabolite) is a metabolite of Irbesartan (I751000), an angiotensin II type 1 (AII1)-receptor antagonist.

Definition

ChEBI: SR-49498 is a member of biphenyls.

Properties of IRBESARTAN RELATED COMPOUND A (25 MG) (1-PENTANOYLAMINO-CYCLOPENTANECARBOXYLIC ACID [2'-(1H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-AMIDE)

Density	1.26
storage temp.	2-8°C
solubility	DMSO (Slightly), Methanol (Slightly)
pka	4.16±0.10(Predicted)
form	neat

Safety information for IRBESARTAN RELATED COMPOUND A (25 MG) (1-PENTANOYLAMINO-CYCLOPENTANECARBOXYLIC ACID [2'-(1H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-AMIDE)

Signal word	Warning
Pictogram(s)	Exclamation Mark Irritant GHS07
GHS Hazard Statements	H302:Acute toxicity,oral H315:Skin corrosion/irritation H319:Serious eye damage/eye irritation H335:Specific target organ toxicity, single exposure;Respiratory tract irritation
Precautionary Statement Codes	P261:Avoid breathing dust/fume/gas/mist/vapours/spray. P280:Wear protective gloves/protective clothing/eye protection/face protection. P301+P312:IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. P302+P352:IF ON SKIN: wash with plenty of soap and water. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

Computed Descriptors for IRBESARTAN RELATED COMPOUND A (25 MG) (1-PENTANOYLAMINO-CYCLOPENTANECARBOXYLIC ACID [2'-(1H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-AMIDE)

New Products

4-Piperidinemethanol Ethyl 2,4-Dihydroxy-6-methylnicotinate Ethyl isonicotinate 3-pyridine methanol N-Methyl 4-chloro-pyridine-2-carboxamide 2-Fluoro-6-iodobenzoic acid 2-((2,6-difluorobenzyl)(ethoxycarbonyl)amino)-4-((dimethylamino)methyl)-5-(4-nitrophenyl)thiophene-3-carboxylic acid Ethyl2-oxo-2,3,9,10-tetrahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline-8(7H)-carboxylate Elinzanetant tert-butyl 2-(4-amino-6-chloropyrimidin-5-yloxy)ethylmethylcarbamate Phenylazomalononitrile 5,6 Dimethoxy-1-indanone 3-Iodophenylacetic acid 2-Hexyn-1-ol Dibenzo-18-crown-6 2-Propanamine, 1-chloro-, hydrochloride (9CI) 3-Pyridineacetonitrile, α-hydroxy- 3-(hexyloxy)-4-(pyridin-3-yl)-1,2,5-thiadiazole N Ethylmethylamine Ethyl Methanesulfonate N N' DimethylEthylenediamine Lead II Bromide Variamine Blue B Diazonium salt N N N'Trimethyl ethylenediamine

Related products of tetrahydrofuran

Irbesartan

2'-[(1H-Tetrazol-5-yl)biphenyl-4-yl]Methanol

IRBESARTAN-D4

DeMethyl Irbesartan